AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019 Net sales decreased 41% to $58.3 million […]
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019 Net sales decreased 41% to $58.3 million […]
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.
